Innovations in Haematology Cell Therapy at ASH ...

By HEOR Staff Writer

December 5, 2025

Advancing Haematology Cell Therapy Innovations at ASH 2025 AstraZeneca is significantly advancing haematology cell therapy with its largest-ever presence at the 67th America...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicine...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chr...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023